Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
4.820
-0.490 (-9.23%)
May 27, 2025, 1:59 PM - Market open
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $429.66 million as of May 27, 2025. Its market cap has increased by 227.36% in one year.
Market Cap
429.66M
Enterprise Value
251.49M
1-Year Change
227.36%
Ranking
Category
Stock Price
$4.82
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has decreased from $1.07B to $429.66M, a decrease of -59.81%. That is a compound annual growth rate of -23.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 473.34M | 83.93% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.72B |
| Johnson & Johnson | 367.98B |
| AbbVie | 323.71B |
| Novo Nordisk | 311.77B |
| UnitedHealth Group | 268.12B |
| Abbott Laboratories | 228.44B |
| Novartis AG | 224.07B |
| AstraZeneca | 218.42B |